Drug-Induced Activation of Dopamine D1 Receptor Signaling and Inhibition of Class I/II Histone Deacetylase Induce Chromatin Remodeling in Reward Circuitry and Modulate Cocaine-Related Behaviors

Department of Psychiatry, Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA 01604, USA.
Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology (Impact Factor: 7.05). 03/2008; 33(12):2981-92. DOI: 10.1038/npp.2008.15
Source: PubMed


Chromatin remodeling, including histone modification, is involved in stimulant-induced gene expression and addiction behavior. To further explore the role of dopamine D(1) receptor signaling, we measured cocaine-related locomotor activity and place preference in mice pretreated for up to 10 days with the D(1) agonist SKF82958 and/or the histone deacetylase inhibitor (HDACi), sodium butyrate. Cotreatment with D(1) agonist and HDACi significantly enhanced cocaine-induced locomotor activity and place preference, in comparison to single-drug regimens. However, butyrate-mediated reward effects were transient and only apparent within 2 days after the last HDACi treatment. These behavioral changes were associated with histone modification changes in striatum and ventral midbrain: (1) a generalized increase in H3 phosphoacetylation in striatal neurons was dependent on activation of D(1) receptors; (2) H3 deacetylation at promoter sequences of tyrosine hydroxylase (Th) and brain-derived neurotrophic factor (Bdnf) in ventral midbrain, together with upregulation of the corresponding gene transcripts after cotreatment with D(1) agonist and HDACi. Collectively, these findings imply that D(1) receptor-regulated histone (phospho)acetylation and gene expression in reward circuitry is differentially regulated in a region-specific manner. Given that the combination of D(1) agonist and HDACi enhances cocaine-related sensitization and reward, the therapeutic benefits of D(1) receptor antagonists and histone acetyl-transferase inhibitors (HATi) warrant further investigation in experimental models of stimulant abuse.


Available from: Schahram Akbarian
  • Source
    • "In addition to these changes in dopaminergic and glutamatergic inputs, ethanol has also shown the capacity to induce post-translational modifications in chromatin, such as acetylation, phosphorylation and methylation of histones on DNA (Grewal and Moazed 2003; Li et al. 2004; Schroeder et al. 2008). According to these findings, it was observed that intermittent ethanol treatment caused changes in the acetylation of histones H3 and H4 in the prefrontal cortex, NAc and striatum, suggesting chromatin remodelling changes, which may mediate long-term alterations , contributing to mitochondrial and cellular damage (Jung and Metzger 2015). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Substance use disorder is an emerging problem concerning to human health, causing severe side effects, including neurotoxicity. The use of illegal drugs and the misuse of prescription or over-the-counter drugs are growing in this century, being one of the major public health problems. Ethanol and cocaine are one of the most frequently used drugs and, according to the National Institute on Drug Abuse, their concurrent consumption is one of the major causes for emergency hospital room visits. These molecules act in the brain through different mechanisms, altering the nervous system function. Researchers have focused the attention not just in the mechanism of action of these drugs, but also in the mechanism by which they damage the nervous tissue (neurotoxicity). Therefore, the goal of the present review is to provide a global perspective about the mechanisms of the neurotoxicity of cocaine and ethanol.
    Neurotoxicity Research 06/2015; 28(3). DOI:10.1007/s12640-015-9536-x · 3.54 Impact Factor
  • Source
    • "A wide variety of environmental stimuli that induce Bdnf transcription have been demonstrated to drive increased acetylation of histones selectively at induced Bdnf promoters in physiologically relevant brain regions. Stimuli that have been shown to induce histone acetylation in conjunction with Bdnf transcription include seizure (Tsankova et al. 2004; Huang et al. 2002), membrane depolarization (Chen et al. 2003a; Martinowich et al. 2003), antidepressant treatment (Tsankova et al. 2006), cocaine administration (Kumar et al. 2005), forced cocaine abstinence (Sadri-Vakili et al. 2010), dopamine D1 receptor agonist administration (Schroeder et al. 2008), and extinction of conditioned fear (Bredy et al. 2007). Among the molecular mechanisms that mediate steady-state changes in histone acetylation at Bdnf, the histone acetyltransferase CBP has been shown to be recruited to the CREB binding site of Bdnf promoter IV in an activity-dependent manner (Hong et al. 2008), and the histone deacetylase HDAC2 has been found to be preferentially associated compared to HDAC1 with Bdnf promoters I and II in vivo (Guan et al. 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Neurotrophins are powerful molecules. Small quantities of these secreted proteins exert robust effects on neuronal survival, synapse stabilization, and synaptic function. Key functions of the neurotrophins rely on these proteins being expressed at the right time and in the right place. This is especially true for BDNF, stimulus-inducible expression of which serves as an essential step in the transduction of a broad variety of extracellular stimuli into neuronal plasticity of physiologically relevant brain regions. Here we review the transcriptional and translational mechanisms that control neurotrophin expression with a particular focus on the activity-dependent regulation of BDNF.
    Handbook of experimental pharmacology 03/2014; 220:67-100. DOI:10.1007/978-3-642-45106-5_4
  • Source
    • "MiR-504 mediates expression of the dopamine D1 receptor [26] and miR-26b is reported to negatively regulate brain-derived neurotrophic factor (BDNF) expression at post-transcriptional level [27]. DR and BDNF are key molecules involved in cocaine addiction [28,29]. These comparisons indicate that these miRNAs may be vulnerable in nervous disorders and may be common targets of drug abuse. "
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNA (miRNA) emerges as important player in drug abuse. Yet, their expression profile in neurological disorder of cocaine abuse has not been well characterized. Here, we explored the changes of miRNA expression in rat hippocampus following repeated cocaine exposure and subsequent abstinence from cocaine treatment. Conditioned place preference (CPP) procedure was used to assess the acquisition and extinction of cocaine-seeking behavior in rats. MiRNA microarray was performed to examine miRNAs levels in rat hippocampus. Quantitative RT-PCR was conducted to further confirm results in microarray study. Finally, bioinformatic predictions were made to suggest potential target genes of cocaine-responsive miRNA in this study. MiRNA array found that 34 miRNA levels were changed in rat hippocampus while acquiring cocaine CPP and 42 miRNAs levels were altered after the cocaine-induced CPP were extinguished, as compared to normal controls. The findings from qRT-PCR study support results from microarray analysis. The current study demonstrated dynamic changes in miRNA expression in rat hippocampus during the acquisition and extinction of cocaine-induced CPP. Some miRNAs which have been previously reported to be involved in brain disorders and drug abuse, including miR-133b, miR-134, miR-181c, miR-191, miR-22, miR-26b, miR-382, miR-409-3p and miR-504, were found to be changed in their expression following repeated cocaine exposure and subsequent abstinence from cocaine treatment. These findings may extend our understanding of the regulatory network underlying cocaine abuse and may provide new targets for the future treatment of drug abuse.
    Journal of Biomedical Science 12/2013; 20(1):96. DOI:10.1186/1423-0127-20-96 · 2.76 Impact Factor
Show more